Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Toshimi Seki"'
Autor:
Yoshitsugu Miyazaki, Michiko Yagoshi, Shu Hashimoto, Shigeki Nakamura, Toshimi Seki, Keishin Sunagawa, Masahiko Sugitani, Atsuko Suzuki, Tomohiro Nakayama
Publikováno v:
Diagnostic Cytopathology. 46:642-644
Autor:
Toshimi Seki, Yoshiaki Kusumi, Toshiya Maebayashi, Takashi Ohta, Masahiko Sugitani, Taku Homma, Atsuo Yoshino, A Suzuki
Publikováno v:
Cytopathology. 28:74-77
Autor:
Hisae Yamamoto, Yukari Hirotani, Hiromi Yamaguchi, Atsuko Suzuki, Hiroko Noda, Haruna Nishimaki, Fumi Nozaki, Toshimi Seki, Yoko Nakanishi, Shinobu Masuda, Xiaoyan Tang
Publikováno v:
Acta Histochemica et Cytochemica
p62, also called sequestosome 1 (SQSTM1), is a multifunctional signaling molecule that affects cell proliferation. Recently, we found accumulation of p62 in apocrine carcinoma of the breast, however, the biological role of p62 expression in apocrine
Autor:
Ichiro Tsujino, Tsutomu Yamada, Fumi Fuchinoue, Tetsuo Shimizu, Toshinori Oinuma, Yukari Obana, Sumie Ohni, Toshimi Seki, Yoko Nakanishi, Norimichi Nemoto, Noriaki Takahashi, Shu Hashimoto, Yoshiaki Kusumi
Publikováno v:
Acta Histochemica et Cytochemica
In patients with inoperable advanced non-small cell lung carcinomas (NSCLCs), histological subtyping using small-mount biopsy specimens was often required to decide the indications for drug treatment. The aim of this study was to assess the utility o
Autor:
Norimichi Nemoto, Noriko Watanabe, Yukari Obana, Toshimi Seki, Yoko Nakanishi, Gou Mizutani, Taku Honma, Sumie Ohni
Publikováno v:
Acta Histochemica et Cytochemica
Molecule targeting therapy using somatostatin (SS) analogues has become a widely accepted modality to treat neuroendocrine tumors (NETs), particularly gastrointestinal (GI) and pancreatic endocrine tumors. On the other hand, little is known about the
Autor:
Masafumi Shiraiwa, Koichi Miyazaki, Katsuyuki Keino, Hiroshi Uchida, Toshimi Seki, Nishiyama Takashi
Publikováno v:
Chemical and Pharmaceutical Bulletin. 53:1190-1193
The total assignment of the (1)H- and (13)C-NMR spectra for TZT-1027 was carried out using various NMR methods (1D, 2D NMR). It was found that TZT-1027 exists in two different conformations resulting from the cis-trans isomerization of the amide bond
Autor:
Hiromi Mori, Koichi Miyazaki, Satoshi Iwamura, Kunio Tsukamoto, Hideyuki Murata, Yoshihiro Kawabe, Keiko Araki, Hiroyuki Ochiai, Toshimi Seki
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 762:155-163
A sensitive and specific analytical method for a potent antitumor agent, TZT-1027, in plasma has been developed using liquid chromatography–mass spectrometry (LC–MS) with [2H4]TZT-1027 as an internal standard (I.S.). A plasma sample was purified
Autor:
Kyoko Komatsu, Yoshinori Takekawa, Eiichi Yamaura, Tsutomu Yamada, Toshimi Seki, Tomoo Yokota, Norimichi Nemoto, Toshirou Mizutani
Publikováno v:
The Journal of the Japanese Society of Clinical Cytology. 37:47-51
子宮頸部の高度異形成を伴った体部原発同所性癌肉腫症例を経験したので, 内膜擦過細胞像を中心に報告する.患者は53歳, 女性.不正性器出血と下腹部痛を主訴に来院し, 内膜増殖症ないし
Autor:
Kikuo Yasuda, Tsutomu Ishimori, Seijiro Honma, Nobuyoshi Minami, Kotaro Gotanda, Toshimi Seki, Takeshi Masuda, Kohichi Hasumi, Tomio Nakao, Kenyu Shibata
Publikováno v:
Chemical and Pharmaceutical Bulletin. 44:2061-2069
A series of novel pyridazinone derivatives (II) having a phenoxypropanolamine moiety was synthesized. Their hypotensive and beta-blocking activities were evaluated after intravenous administration of the compounds to anesthetized rats. Among them, th
Autor:
Rikio Ohuchi, Takayuki Takezaki, Kikuo Yasuda, Toshimi Seki, Hiroshi Ohuyabu, Tsutomu Ishimori
Publikováno v:
Chemical and Pharmaceutical Bulletin. 42:1609-1616
A series of hydrazinopyridazine derivatives combined with a beta-blocking side chain were synthesized. When they were given intravenously to anesthetized rats, some of them exhibited both hypotensive and beta-blocking activities. Their structure-acti